Furonazide
Chemical compound
From Wikipedia, the free encyclopedia
Furonazide is a crystalline tuberculostatic drug substance with a reported melting point of 199-201.5 °C.[1]
| Names | |
|---|---|
| Preferred IUPAC name
N′-[1-(Furan-2-yl)ethylidene]pyridine-4-carbohydrazide | |
| Other names
4-Pyridinecarboxylic acid [1-(2-furanyl)ethylidene]hydrazide Furilazone Clitizina Menazone FKI | |
| Identifiers | |
3D model (JSmol) |
|
| ChEBI | |
| ChemSpider | |
| ECHA InfoCard | 100.020.375 |
| EC Number |
|
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C12H11N3O2 | |
| Molar mass | 229.239 g·mol−1 |
| Appearance | crystals |
| Melting point | 199 to 201.5 °C (390.2 to 394.7 °F; 472.1 to 474.6 K) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Synthesis
Applications
Furonazide has shown bacteriostatic action and is tuberculostatic at levels of 10−8 molar.[1] The in vitro antibacterial activity of furonazide against Bacillus Calmette-Guerin was found to be essentially equal to that of isoniazid on an equimolar basis.[3] In vivo studies in the guinea pig showed furonazide slightly more active than isoniazid as a tuberculostatic agent.[4] The drug has relatively low toxicity. The median lethal dose (LD50, rat oral) was reported as 2,600 mg/kg.[5]
